On August 30, 2018, Dalvir Gill tendered his resignation from the Board of Directors of Sun BioPharma, Inc., effective immediately. Mr. Gill is resigning to focus on other responsibilities. There are no disagreements between Mr. Gill and the Company relating to the Company's operations, policies or practices that resulted in Mr. Gill's decision to resign.